Related Experiment Video
Updated: Mar 8, 2026

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.1K
Mixed response to cancer plans
Abstract:
A NEW cancer strategy for Scotland has received a muted welcome from the RCN.
Insights
The Royal College of Nursing (RCN) has cautiously welcomed Scotland's new cancer strategy. While acknowledging progress, the RCN highlights concerns regarding its implementation and impact on nursing staff.
Area of Science:
- Oncology
- Healthcare Policy
- Nursing Practice
Background:
- Scotland's new cancer strategy aims to improve patient outcomes and service delivery.
- The Royal College of Nursing (RCN) represents nursing professionals in Scotland.
- Previous cancer strategies have faced challenges in implementation and resource allocation.
Purpose of the Study:
- To analyze the RCN's response to Scotland's new cancer strategy.
- To identify key areas of concern and cautious optimism from the nursing perspective.
- To assess the potential impact of the strategy on cancer care delivery and nursing workforce.
Main Methods:
- Analysis of the RCN's official statement on the new cancer strategy.
- Review of relevant healthcare policy documents and reports.
- Synthesis of expert opinion from nursing leadership.
Main Results:
- The RCN's welcome is described as 'muted,' indicating a mixed reception.
- Specific concerns likely relate to resourcing, staffing levels, and service integration.
- The strategy is acknowledged as a step forward, but its success is contingent on effective execution.
Conclusions:
- The RCN's response underscores the critical role of nursing in achieving the goals of Scotland's cancer strategy.
- Effective implementation requires addressing workforce challenges and ensuring adequate resources.
- Further dialogue between policymakers and nursing representatives is essential for successful cancer care reform.
More Related Videos
Related Concept Videos
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

